Neurologist paid up to $20,000 a year by biotech companies removed from FDA dementia
A neurologist paid up to $20,000 a year by biotech companies has been removed from a Food and Drug Administration (FDA) advisory committee.Dr David Weisman was removed as a temporary voting member by the agency after he was found to have…